Interruptions in rheumatology subspecialty care among patients with rheumatoid arthritis.
To identify factors associated with interruptions in care from rheumatologists among patients with rheumatoid arthritis (RA).
A person-time analysis was used to examine the association of medical insurance status, income, health status, treatment by a primary care physician, and presence of comorbid conditions with interruptions in rheumatology subspecialty care in a cohort of 161 patients with RA followed prospectively for up to 10 years.
An interruption was defined as a 6-month period during which a patient was not treated by a rheumatologist.
Each patient had at least one interruption.
Interruptions in rheumatology care occurred more commonly during periods when patients reported no medical insurance coverage than when they had medical insurance coverage (relative risk, RR=1.49 ; 95% confidence interval, CI=1.05,2. 11).
Interruptions in care were more common during intervals in which patients reported at least a 40% improvement in functional disability (RR=1.30 ; 95% CI=1.03,1.63), but interruptions were not associated with either absolute or relative changes in pain or global arthritis status.
Interruptions in rheumatology care also occurred more commonly during periods when patients reported seeing a primary care physician (RR=2.07 ; 95% CI=1.71,2.50), and when they reported having a comorbid condition (RR=1.37 ; 95% CI=1.06,1.77).
Income was not associated with interruptions in care.
Lack of medical insuran...
Mots-clés Pascal : Polyarthrite rhumatoïde, Soin, Interruption programme, Traitement, Facteur risque, Epidémiologie, Etats Unis, Amérique du Nord, Amérique, Homme, Chronique, Système ostéoarticulaire pathologie, Rhumatisme inflammatoire, Immunopathologie, Maladie autoimmune
Mots-clés Pascal anglais : Rheumatoid arthritis, Care, Program interruption, Treatment, Risk factor, Epidemiology, United States, North America, America, Human, Chronic, Diseases of the osteoarticular system, Inflammatory joint disease, Immunopathology, Autoimmune disease
Notice produite par :
Inist-CNRS - Institut de l'Information Scientifique et Technique
Cote : 96-0068195
Code Inist : 002B15D. Création : 199608.